A new source for Magnesium Sulphate 50%, 10ml, has received a positive recommendation for procurement from the WHO Expert Review Panel (ERP).
The medicine, which will soon be available for procurement via the AccessRH product catalog
, is a life-saving maternal health medicine used in the treatment of eclampsia and preeclampsia — the two leading causes of maternal death.
Life-saving commodities such as magnesium sulphate are often inaccessible to vulnerable populations resulting in a number of women dying of causes that are preventable and treatable. As the lead agency for providing a world where every child birth is safe, UNFPA, together with WHO is working to address commodity-related gaps ensuring access to quality assured life-saving maternal health medicines.
For questions, please contact UNFPA at firstname.lastname@example.org